ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Karolinska Development's portfolio company Modus Therapeutics has successfully dosed first cohort in phase 1 study of subcutaneously administered sevuparin
February 24, 2019Karolinska Development's portfolio company Modus Therapeutics announces today that the first cohort has been successfully dosed in its phase 1 study to explore the pharmacokinetics, safety and tolerability of subcutaneous sevuparin injections in healthy a -
Piramal Enterprises to acquire portfolio of drugs Mallinckrodt
February 07, 2017The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the US, and two pain management products, which are currently under development
Pharma Sources Insight January 2025
